MA31905B1 - DERIVES D'AMIDES DE L'ACIDE 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha] IMIDAZOLE-3-CARBOXYLIQUE - Google Patents

DERIVES D'AMIDES DE L'ACIDE 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha] IMIDAZOLE-3-CARBOXYLIQUE

Info

Publication number
MA31905B1
MA31905B1 MA32900A MA32900A MA31905B1 MA 31905 B1 MA31905 B1 MA 31905B1 MA 32900 A MA32900 A MA 32900A MA 32900 A MA32900 A MA 32900A MA 31905 B1 MA31905 B1 MA 31905B1
Authority
MA
Morocco
Prior art keywords
imidazo
dihydro
imidazole
carboxylic acid
amide derivatives
Prior art date
Application number
MA32900A
Other languages
Arabic (ar)
English (en)
Inventor
Rene M Lemieux
Antonio Jose Del Moral Barbosa
Joerg Martin Bentzien
Steven Richard Brunette
Zhidong Chen
Derek Cogan
Donghong A Gao
Alexander Heim-Riether
Joshua Courtney Horan
Jennifer A Kowalski
Michael David Lawlor
Weimin Liu
Bryan Mckibben
Craig Andrew Miller
Neil Moss
Matt Aaron Tschantz
Zhaoming Xiong
Hui Yu
Yang Yu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MA31905B1 publication Critical patent/MA31905B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des dérivés d'amide de l'acide 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylique qui présentent un bon effet d'inhibition sur l'interaction des cam (molécules d'adhésion cellulaire) et des intégrines leucocytaires et sont donc utiles dans le traitement d'une maladie inflammatoire.
MA32900A 2007-11-29 2010-06-09 DERIVES D'AMIDES DE L'ACIDE 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha] IMIDAZOLE-3-CARBOXYLIQUE MA31905B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99096007P 2007-11-29 2007-11-29
US4795708P 2008-04-25 2008-04-25
PCT/US2008/084149 WO2009070485A1 (fr) 2007-11-29 2008-11-20 Dérivés d'amides de l'acide 6,7-dihydro-5h-imidazo[1,2-α]imidazole-3-carboxylique

Publications (1)

Publication Number Publication Date
MA31905B1 true MA31905B1 (fr) 2010-12-01

Family

ID=40193954

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32900A MA31905B1 (fr) 2007-11-29 2010-06-09 DERIVES D'AMIDES DE L'ACIDE 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha] IMIDAZOLE-3-CARBOXYLIQUE

Country Status (32)

Country Link
US (1) US8552205B2 (fr)
EP (1) EP2225238B1 (fr)
JP (1) JP5485164B2 (fr)
KR (1) KR20100101095A (fr)
CN (1) CN101889011B (fr)
AR (1) AR069513A1 (fr)
AU (1) AU2008329909B2 (fr)
BR (1) BRPI0819831A2 (fr)
CA (1) CA2705583A1 (fr)
CL (1) CL2008003576A1 (fr)
CO (1) CO6210701A2 (fr)
CY (1) CY1115857T1 (fr)
DK (1) DK2225238T3 (fr)
EA (1) EA017688B1 (fr)
EC (1) ECSP10010196A (fr)
ES (1) ES2525237T3 (fr)
HK (1) HK1145683A1 (fr)
HR (1) HRP20141171T1 (fr)
IL (1) IL205189A (fr)
MA (1) MA31905B1 (fr)
MX (1) MX2010004995A (fr)
MY (1) MY151004A (fr)
NZ (1) NZ585640A (fr)
PE (1) PE20091427A1 (fr)
PL (1) PL2225238T3 (fr)
PT (1) PT2225238E (fr)
RS (1) RS53602B1 (fr)
SI (1) SI2225238T1 (fr)
TN (1) TN2010000240A1 (fr)
TW (2) TWI475990B (fr)
UY (1) UY31493A1 (fr)
WO (1) WO2009070485A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2446352T3 (es) * 2009-06-02 2014-03-07 Boehringer Ingelheim International Gmbh Derivados de amidas del ácido 6,7-dihidro-5H-imidazo[1,2-a]imidazol-3-carboxílico
WO2010141330A1 (fr) * 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Dérivés d'amides d'acide 6,7-dihydro-5h-imidazo [1,2-a] imidazole-3-carboxylique
US9056858B2 (en) 2009-10-21 2015-06-16 Boehringer Ingelheim International Gmbh Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists
US8912221B2 (en) * 2010-12-27 2014-12-16 Hoffmann-La Roche Inc. Biaryl amide derivatives
SG194621A1 (en) * 2011-04-27 2013-12-30 Shionogi & Co 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
TW201311678A (zh) 2011-08-03 2013-03-16 Kyowa Hakko Kirin Co Ltd 二苯并氧呯衍生物
KR102049534B1 (ko) 2011-10-03 2019-11-27 오게다 에스.에이. 선택적 NK-3 수용체 길항제로서의 신규한 키랄 N-아실-5,6,7,(8-치환된)-테트라히드로-[1,2,4]트리아졸로[4,3-a]피라진, 의약 조성물, NK-3 수용체 매개 질환에 사용하는 방법 및 그의 키랄 합성법
WO2016058896A1 (fr) 2014-10-14 2016-04-21 Syngenta Participations Ag Procédé pour la préparation de 1-(3,5-dichloro-4-fluorophényl)-2,2,2-trifluoroéthanone
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
CN106631827B (zh) * 2016-12-30 2018-10-23 上海毕得医药科技有限公司 一种(1-环丙基-1-甲基)乙基胺及其盐酸盐的合成方法
CN109369432B (zh) * 2018-11-02 2021-06-25 永农生物科学有限公司 (s)-4-氯-2-氨基丁酸酯的制备方法
JP2023506917A (ja) 2019-12-20 2023-02-20 バイエル・アクチエンゲゼルシヤフト 置換チオフェンカルボキサミド、チオフェンカルボン酸およびその誘導体
CN111848521A (zh) * 2020-08-26 2020-10-30 韶远科技（上海)有限公司 一种2-取代-4-烷氧基咪唑化合物的制备方法
WO2024013736A1 (fr) * 2022-07-12 2024-01-18 Adama Makhteshim Ltd. Procédé de préparation de benzamides substitués

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2015493A1 (fr) 1968-08-12 1970-04-30 Sumitomo Chemical Co
DK123717B (da) 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
JPS5136332B1 (fr) 1970-12-09 1976-10-07
EP0091596B1 (fr) 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Hydantoins, préparation et application
JPS63270665A (ja) 1987-04-30 1988-11-08 Wakamoto Pharmaceut Co Ltd イミダゾ−ル誘導体
JPS63270667A (ja) 1987-04-30 1988-11-08 Wakamoto Pharmaceut Co Ltd １−ベンジルイミダゾ−ル誘導体
US5306822A (en) 1988-05-25 1994-04-26 Warner-Lambert Company Arylmethylenyl derivatives of oxazolidinone
IE940525L (en) 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
US5208250A (en) 1988-05-25 1993-05-04 Warner-Lambert Company Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
US4977270A (en) 1988-12-01 1990-12-11 Ici Americas Inc. Substituted 2,4-dioxodiazolidines and -thiadiazolidines and their use as herbicides
US4911748A (en) 1988-12-22 1990-03-27 Ici Americas Inc. Herbicidal 5-substituted-3-phenyl-imidazolidine-2,4-diones
JPH04273877A (ja) 1991-02-28 1992-09-30 Sumitomo Pharmaceut Co Ltd 新規なイミダゾール誘導体
CA2083891A1 (fr) 1991-12-03 1993-06-04 Angus Murray Macleod Composes heterocycliques, compositions et utilisation therapeutique
JPH05188631A (ja) 1992-01-10 1993-07-30 Mita Ind Co Ltd 電子写真感光体
TW521073B (en) 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
US20040006011A1 (en) 1996-07-12 2004-01-08 Gour Barbara J. Peptidomimetic modulators of cell adhesion
JP2001525797A (ja) 1996-10-28 2001-12-11 ザ ユニバーシティ オブ ワシントン ウイルスｒｎａへのミスコーディングリボヌクレオシドアナログの組込みによるウイルス変異の誘導
BR9811260A (pt) 1997-03-03 2000-08-08 Boehringer Ingelheim Pharma Pequenas moléculas úteis no tratamento de doença inflamatória
US6355664B1 (en) 1997-03-03 2002-03-12 Boehringer Ingelheim Pharmaceuticals, Inc. Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
NZ502872A (en) 1997-08-28 2002-10-25 Novartis Ag Mevinolin and compaction as LFA-1 antagonists for treating autoimmune diseases
EP1063982B1 (fr) 1998-03-27 2007-02-14 Genentech, Inc. Antagonistes destines au traitement de troubles induits par le recepteur d'adhesion de cd11/cd18
WO2001007048A1 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules utiles pour le traitement de troubles inflammatoires
US6492408B1 (en) 1999-07-21 2002-12-10 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
WO2001007052A1 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules des plus utiles dans le traitement de maladies inflammatoires
WO2001007044A1 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules utiles pour le traitement de maladies inflammatoires
WO2001006984A2 (fr) 1999-07-21 2001-02-01 Boehringer Ingelheim Pharmaceuticals, Inc. Petites particules utiles pour le traitement de maladies inflammatoires
MXPA02003977A (es) 1999-10-20 2003-09-25 Tanabe Seiyaku Co Inhibidores de adhesion de celula mediada por al°2.
WO2002050080A1 (fr) 2000-12-19 2002-06-27 Boehringer Ingelheim Pharmaceuticals, Inc. Petites molecules utiles dans le traitement de maladies inflammatoires
RU2003126188A (ru) * 2001-01-26 2005-03-27 Бристол-Маерс Сквибб Компани (Us) Имидазолильные производные как ингибиторы кортикотропин-рилизинг фактора
US20030232817A1 (en) 2002-05-29 2003-12-18 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful for the treatment of inflammatory disease
US6844360B2 (en) 2002-10-30 2005-01-18 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
US6852748B1 (en) 2002-10-30 2005-02-08 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
WO2006014828A1 (fr) 2004-07-27 2006-02-09 Boehringer Ingelheim International, Gmbh Synthese d'amides d'acide 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonique
US7572921B2 (en) 2005-04-05 2009-08-11 Boehringer Ingelheim International Gmbh Substituted benzylimidazoles useful for the treatment of inflammatory diseases
EP1868603A1 (fr) 2005-04-06 2007-12-26 Boehringer Ingelheim Pharma GmbH & Co. KG Derives d'amides, esters et acides ý6,7-dihydro-5h-imidazo ý1,2-alpha¨imidazole-3-sulfonyl¨-azetedino-carboxyliques et leur utilisation comme anti-inflammatoires
KR20080025067A (ko) * 2005-05-19 2008-03-19 베링거 인겔하임 인터내셔날 게엠베하 6,7-디하이드로-5Ｈ-이미다조[1,2-ａ]이미다졸-3-설폰산의유도체
TW200831488A (en) 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
RU2483072C2 (ru) 2007-11-29 2013-05-27 Актелион Фармасьютиклз Лтд Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12
CL2008003511A1 (es) 2007-11-29 2010-02-19 Metabasis Therapeutics Inc Compuestos derivados nucleotidicos, inhibidores de polimerasa ns5b del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
JP2009149609A (ja) 2007-11-29 2009-07-09 Sumitomo Chemical Co Ltd アミド化合物及びその用途
EP2080758A3 (fr) 2007-11-29 2009-08-26 Bayer CropScience AG Delta-1-pyrrolines substituées par halogène
WO2010141330A1 (fr) 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Dérivés d'amides d'acide 6,7-dihydro-5h-imidazo [1,2-a] imidazole-3-carboxylique
ES2446352T3 (es) 2009-06-02 2014-03-07 Boehringer Ingelheim International Gmbh Derivados de amidas del ácido 6,7-dihidro-5H-imidazo[1,2-a]imidazol-3-carboxílico

Also Published As

Publication number Publication date
UY31493A1 (es) 2009-07-17
PE20091427A1 (es) 2009-10-19
EA017688B1 (ru) 2013-02-28
PL2225238T3 (pl) 2015-03-31
CY1115857T1 (el) 2017-01-25
KR20100101095A (ko) 2010-09-16
CN101889011B (zh) 2014-05-28
JP2011505359A (ja) 2011-02-24
US20110224188A1 (en) 2011-09-15
TWI475990B (zh) 2015-03-11
BRPI0819831A2 (pt) 2019-09-24
HK1145683A1 (en) 2011-04-29
AU2008329909A1 (en) 2009-06-04
WO2009070485A1 (fr) 2009-06-04
MX2010004995A (es) 2010-05-20
HRP20141171T1 (hr) 2015-01-30
TW201417810A (zh) 2014-05-16
EA201000866A1 (ru) 2010-12-30
MY151004A (en) 2014-03-31
AU2008329909A8 (en) 2010-06-03
RS53602B1 (en) 2015-02-27
EP2225238B1 (fr) 2014-09-03
AR069513A1 (es) 2010-01-27
EP2225238A1 (fr) 2010-09-08
US8552205B2 (en) 2013-10-08
ES2525237T3 (es) 2014-12-19
CA2705583A1 (fr) 2009-06-04
TWI475991B (zh) 2015-03-11
AU2008329909B2 (en) 2013-10-03
IL205189A0 (en) 2010-12-30
PT2225238E (pt) 2014-12-18
TN2010000240A1 (en) 2011-11-11
IL205189A (en) 2014-09-30
NZ585640A (en) 2011-03-31
ECSP10010196A (es) 2010-07-30
CO6210701A2 (es) 2010-10-20
SI2225238T1 (sl) 2014-12-31
WO2009070485A8 (fr) 2014-08-14
CN101889011A (zh) 2010-11-17
DK2225238T3 (en) 2014-11-24
TW200922562A (en) 2009-06-01
JP5485164B2 (ja) 2014-05-07
CL2008003576A1 (es) 2010-02-12

Similar Documents

Publication Publication Date Title
MA31905B1 (fr) DERIVES D'AMIDES DE L'ACIDE 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha] IMIDAZOLE-3-CARBOXYLIQUE
EA200971130A1 (ru) Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
EA200870592A1 (ru) Триазолопиразиновые соединения, пригодные для лечения дегенеративных и воспалительных заболеваний
EP1924717A4 (fr) Méthodes d'amélioration de la capacité de deshydratation de boue avec un traitement d'alpha-amylase
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
UA85559C2 (en) Aminobenzophenone compounds
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
WO2007022518A8 (fr) Nouvelles utilisations de proteines glucoregulatoires
EA200700909A1 (ru) Азаиндолкарбоксамиды
NO20052579L (no) Derviater av (6,7-dihydro-5h-imidazo(i,2-a) imidazol-3-sulfonylamino)-pro pionamid
MA29797B1 (fr) DERIVES DE LA PYRROLOPYRIMIDINE INHIBITEURS DE LA Syk
MA28583B1 (fr) Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale
WO2007070613A3 (fr) Analogues de la rifamycine et leurs utilisations
WO2007150002A3 (fr) PROMÉDICAMENTS DE LA 5-AMINO-3-(3'-DÉSOXY-ß-D-RIBOFURANNOSYL)-THIAZOLO[4,5-D]PYRIMIDIN-2,7-DIONE
WO2007122382A3 (fr) Lycopène pour le traitement d'une dysmétabolie
WO2007121124A3 (fr) Composés organiques et leurs utilisations
MA30485B1 (fr) Aminothiazoles et leurs utilisations
WO2007144057A3 (fr) Carbone antimicrobien
WO2008112903A3 (fr) Modifications génétiques sur le chromosome 16 et procédés d'utilisation de celles-ci pour le diagnostic et le traitement du diabète de type i
WO2007117559A3 (fr) Inhibiteurs de la rénine
WO2007027233A3 (fr) Derives d'acide 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonique
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
MX2011012717A (es) Derivados de amidas del acido 6,7-dihidro-5h-imidazo[1,2-a]imidazo l-3-carboxilico.
WO2008034735A3 (fr) Dérivés 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazépine
EA201200111A1 (ru) Новое применение ингибиторов глутаминилциклазы